Analysis Of Income And Expense [Abstract]

Optomed Oyj - Filing #3684574

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
15,040,000 EUR
15,100,000 EUR
Material income and expense [abstract]
Finance income (cost)
441,000 EUR
545,000 EUR
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense
8,931,000 EUR
8,699,000 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
2,499,000 EUR
2,193,000 EUR
Other expenses, by nature
4,204,000 EUR
3,374,000 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
329,000 EUR
329,000 EUR
283,000 EUR
283,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
5,778,000 EUR
329,000 EUR
5,450,000 EUR
4,157,000 EUR
4,441,000 EUR
283,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
5,778,000 EUR
4,157,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.